M. D. Anderson Cancer Center Postdoc Faked Results Of Novartis AG (NVS) Brain Tumor Study
Ex-Eli Lilly and Company (LLY) Scientists Fighting Fraud Charges Now Battle Over Leak Of Internal Documents
Biota Pharmaceuticals, Inc. (BOTA) Stock Crashes As Influenza Drug Laninamivir Octanoate Fails Mid-Stage Trial; Stock Down -37.07% Before The Market Opens
As The Pursuit For Allergan Inc. (AGN) Continues, Valeant Pharmaceuticals International (VRX) Hunts For More Deals—Including Contact Lenses
More Drama At Sarepta Therapeutics (SRPT) As Chairman Of The Board Abruptly Steps Down, Interim Chairman Named
Novartis AG (NVS) Malaria Pill KAE609 Shows Promise As Best Drugs Fail
Genmab A/S (GEN.CO), GlaxoSmithKline (GSK)'s Ofatumumab Meets Primary Endpoint In Late-Stage Study
Benefit Of Baxter International, Inc. (BAX)'s Immune Therapy Outweighs Risk: FDA Panel
AstraZeneca PLC (AZN) Touts 2nd Quarter Results After Fending Off Pfizer Inc. (PFE), CEO And Investors Rejoice
As Sanofi (France) (SAN.PA) Pushes to Grow Faster, A Top U.S. Exec Is Leaving
Google Inc. Exec Joins Illumina, Inc. (ILMN)'s Board Of Directors
Menlo Park's Avalanche Biotechnologies (AAVL) Rolls Onto Nasdaq, Raises $102 Million For Its IPO
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Bag BioMarin Pharmaceutical Inc. (BMRN)'s Special FDA Priority Review Voucher For $67.5 Million
Novartis AG (NVS) Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner
AstraZeneca PLC (AZN) Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK), And Roche (RHHBY)
Flailing Dendreon Corporation (DNDN) Brings In Ex-Johnson & Johnson (JNJ) Exec For Top CEO Post
FDA Panel Reviews Safety Of Baxter International, Inc. (BAX)'s Experimental Drug For Immune System Disorders
Meda AB (MEDA-A.ST) Bags Rottapharm $3.08 Billion To Create A European Pharma Powerhouse
See All News >
Too Much Hype Doomed Once-Successful Wyeth (WYE) CEO
FDA Will Regulate Thousands Of Cancer, Genetic, And Other Diagnostic
Billionaire Doctor-Turned Entrepreneur Buys World's Most Powerful DNA Sequencer
UK Startup InoCardia Creating Animal-Free Drug Testing
"Rewired" Mice Show Signs Of Longer Lives With Fewer Age-related Illnesses, Wistar Institute Study
Study Of Twins Discovers Gene Mutation Linked To Short Sleep Duration, Children's Hospital of Philadelphia Reveals
University of Texas Study: Noise-Induced Hearing Loss Alters Brain Responses To Speech
Puma Biotechnology (PBYI)'s Overnight Billionaire On One Of His Keys To Success
Insiders Reveal Valeant Pharmaceuticals International (VRX)'s Cost Cutting May Have Gone Too Far
Gilead Sciences, Inc. (GILD) Popular Amongst Latest 13F Filers
Psychologists Discover A Surprising Thing Happens To Kids Who Read Harry Potter, University of Modena Reveals
Common Pesticide Linked To Slow Metabolism, Obesity, And Diabetes, University of California, Davis (UCD) Study
Tree Nuts May Fight Metabolic Disease, Diabetes, St. Michael's Hospital Study
Soy May Help Women's Hearts If They Start Early, Wake Forest University School of Medicine Study
8 Fascinating Facts About Tears You Need To Know, University of California, Berkeley (CAL) Reveals
Light Shed On How Depression Is Related To Dementia, Rush University Medical Center Study
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story
Could The Ebola Virus Become A Threat In The U.S.?
See All News >
Amgen (AMGN) Eliminating Up To 2,900 Jobs; Will Shutter Seattle, Bothell Sites
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story
Rumor: Sarepta Therapeutics (SRPT) Chairman Moves To Keep CEO Out Of FDA Meetings
Three Things To Take Away From Amgen (AMGN)'s Big Restructuring
GlaxoSmithKline (GSK) May Separate Businesses
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Drug Alirocumab Cuts Cholesterol In Nine Late-Stage Trials
BioPharm Executive: Have Drugs Finally Been Priced Too High?
Amid Cuts, Amgen (AMGN) To Add Jobs In Cambridge, Massachusetts
Incyte Corporation (INCY) Partners With Genentech (RHHBY) To Help With Cancer Immunotherapy Trials
AstraZeneca PLC (AZN) Scoops Up Almirall Lung Drugs For Up To $2.1 Billion
Pfizer Inc. (PFE) Grabs Baxter International, Inc. (BAX)'s Portfolio Of Marketed Vaccines For $635 Million
Pfizer Inc. (PFE) CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC (AZN) Intentions
IMPAX Laboratories, Inc. (IPXL) Parkinson's Drug Future Shaky As FDA Cites Factory Issues
Second Failure Of The Month As Targacept, Inc. (TRGT) Halts Development Of Bladder Drug, Shares Plunge
Novartis AG (NVS) Layoffs: Game-Changing Tips For Today‚Äôs Job Seeker
Pfizer Inc. (PFE)'s Need For A Deal Looms Larger As Second Quarter Profits Sinks 79 Percent
Drinking In Midlife Doubles Chance Of Memory Problems In Later Life, University of Exeter Study
Wide-Faced Men Negotiate Nearly $2,200 Larger Signing Bonus, University of California, Riverside Study
See All News >